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Abstract 21 
Bacteriophages are viruses that infect bacteria. There are an estimated 10
31
 phage on the 22 
planet, making them the most abundant form of life. We are rapidly approaching the 23 
centenary of their identification, and yet still have only a limited understanding of their role 24 
in the ecology and evolution of bacterial populations. Temperate prophage carriage is often 25 
associated with increased bacterial virulence. The rise in use of technologies, such as genome 26 
sequencing and transcriptomics have highlighted more subtle ways in which prophages 27 
contribute to pathogenicity.  This review discusses the current knowledge of the multifaceted 28 
effects that phage can exert on their hosts and how this may contribute to bacterial adaptation 29 
during infection. 30 
 31 
Introduction: Lifestyle Choices: A good work-life balance 32 
Bacteriophages (phage) are viruses that infect and replicate within bacterial hosts and 33 
are ubiquitous and abundant in every niche studied so far on the planet (Roux et al., 2015). 34 
They are broadly divided into two categories. Virulent phage follow a strictly productive lytic 35 
lifecycle whereas temperate phage switch between dormant and productive states. All phage 36 
infect the host bacterium by binding to specific surface receptors and injecting their genome 37 
into the cytoplasm. Virulent (lytic) phage infection immediately commandeers the bacterial 38 
replicative machinery for multiplication. Phage genes encode structural head and tail proteins 39 
and lytic enzymes that cause bacterial cell lyses, releasing lytic phage progeny into the 40 
environment. The characteristics of lytic phage offer an attractive alternative to antibiotics. 41 
Phage therapy has been widely used in the former Soviet Union (Hraiech et al., 2015) and 42 
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rapid spread of multi-drug-resistant infections has prompted renewed interest in phage-based 43 
therapies worldwide. 44 
Temperate (lysogenic) phage follow an alternative life cycle involving integration of 45 
their genome into the host chromosome to become a prophage. In this state the phage DNA 46 
replicates along with the host cell (lysogen) and is maintained in the bacterial population.  47 
Lysogenic phage can switch to a lytic lifecycle, particularly in response to environmental 48 
stresses (Figure 1). Lambdoid phage employ repressor genes such as cI, which act as a 49 
genetic switch to control the balance between lysis and lysogeny (Ptashne, 2004). Expression 50 
of these repressors prevents the lytic pathway and maintains the prophage state. The CI 51 
repressor also inhibits integration of any incoming phage genomes conferring immunity to 52 
super-infection. There are a wide range of other phage-resistance mechanisms (reviewed in 53 
(Labrie et al., 2010). 54 
The balance between lytic and lysogenic states is thought to be largely dependent on 55 
the metabolic condition of the bacterial host cell (Lieb, 1953). Temperate phage infection 56 
tends towards lysogeny in starving cells and this is thought to be a phage survival tactic 57 
during periods of resource limitation (Stewart & Levin, 1984). Integration into the 58 
chromosome is facilitated by integrase and transposase enzymes that can act at specific sites 59 
or randomly. This means that lysogenic phage can drive bacterial diversity by introducing 60 
mutations with each integration event. Active prophage retain the ability to switch to a lytic 61 
cycle of productive replication. This occurs spontaneously in a proportion of cells within a 62 
population of lysogenic bacteria. Induction of lambdoid phages into the lytic cycle has been 63 
well characterised and often linked to the SOS response triggered by DNA damage. Prophage 64 
induction is thought to be another survival strategy to aid phage escape from a host cell at 65 
risk of death (Refardt & Rainey, 2010). Potent inducers of DNA damage and phage induction 66 
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include physical and chemical mutagens such as UV, mitomycin C and reactive oxygen 67 
species (Aanaes et al., 2011). Several antibiotics have also been shown to trigger the lytic 68 
cycle, particularly those that target DNA replication (fluoroquinolones such as norfloxacin 69 
and ciprofloxacin) (Matsushiro et al., 1999, James et al., 2001; Fothergill et al., 2011; 70 
Meessen-Pinard et al., 2012; López et al., 2014).  71 
During lysogeny, mutations commonly lead to the formation of a defective (cryptic) 72 
phage, locking the once mobile element in to the host chromosome (Fischer-Fantuzzi and 73 
Calef., 1964; Bobay et al., 2014). The frequency of defective (domesticated) prophage may 74 
be grossly underestimated. They can be hard to identify as genome degradation often results 75 
in deletion of recognisable phage genes (Mizutani et al., 1999, Bobay et al., 2014). 76 
  77 
Prophage contribution to infection 78 
Lysogenic infection and subsequent expression by the host of phage encoded genes is 79 
termed lysogenic conversion, and can have profound effects on bacterial phenotype. 80 
Prophages often encode “morons” that are not directly involved in viral replication and can 81 
confer a benefit to their bacterial host. Such genes are independent transcriptional units of 82 
DNA that are expressed whilst the phage is in the prophage state (Juhala et al., 2000). 83 
Morons can include genes that enhance the virulence of their bacterial host, either directly 84 
(e.g. phage-encoded toxins), or indirectly, by enhancing the ecological fitness of bacteria 85 
during infection (Hacker & Carniel, 2001). The role of temperate phage in disease situations 86 
is thus becoming increasingly recognised.  87 
The recent growth in whole bacterial genome sequencing has revealed high numbers 88 
of integrated prophage (Hayashi et al., 2001, Winstanley et al., 2009, Wang et al., 2010, 89 
Matos et al., 2013). Pathogenic strains have been shown to carry a greater proportion of 90 
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phage-related genes than non-pathogenic strains (Busby et al., 2013), many maintaining 91 
multiple prophages in the same chromosome (Hayashi et al., 2001, Winstanley et al., 2009). 92 
For example, the majority of the genetic difference between avirulent and virulent strains of 93 
Escherichia coli is due to mobile genetic elements, notably phages (Hayashi et al., 2001, 94 
Ohnishi et al., 2002). Table 1 summarises some of the major phage-encoded bacterial 95 
virulence factors that have been identified. 96 
Exotoxins: The concept of lysogenic conversion was first introduced in 1927 when it 97 
was demonstrated that a filterable agent (later identified as a bacteriophage) could convert 98 
previously non-toxigenic Streptococci into toxin producers (Frobisher & Brown, 1927). It 99 
wasn’t until the 1950s that phage transduction was shown to be responsible for toxigenic 100 
conversion of avirulent Corynebacterium diptheriae to produce a potent exotoxin and 101 
become highly pathogenic to the animal host (Groman, 1953, Groman, 1955). Since then 102 
there have been numerous reports of phage-encoded exotoxins that enhance the virulence of 103 
their bacterial hosts, including Vibrio cholera, Staphylococcus aureus, Clostridium botulinum 104 
and E. coli (reviewed in (Casas & Maloy, 2011)). Shiga toxins (Stx), major virulence factors 105 
of Shigatoxigenic E. coli (STEC) are produced by a group of temperate Stx phages. The stx2 106 
genes are located in the phage late gene region and are expressed when the prophage is 107 
triggered into the lytic cycle (Wagner et al., 2002).  108 
Phage-encoded exotoxins are likely to contribute to bacterial fitness, but the exact 109 
mechanism remains unclear (for a review on the evolution of bacterial virulence, see (Levin 110 
& Svanborg Eden, 1990)). Phage-encoded exotoxins are well characterised as they often have 111 
a large impact on bacterial virulence. However, prophage can have more subtle effects on 112 
host phenotype, conferring a benefit to the host bacterium by enhancing colonisation or 113 
competitiveness in an animal host (Fortier & Sekulovic, 2013).    114 
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Adhesion and Invasion: One of the crucial first stages of bacterial infection is 115 
attachment to cells. Some phage-encoded shiga-toxins provide extra virulence by facilitating 116 
adherence of STEC to gut epithelial cells in a murine model of infection (Robinson et al., 117 
2006). Several stx phages (e.g. 933W isolated from E. coli O157:H7) also possess a lom gene 118 
homologue that encodes an outer membrane protein necessary for adhesion to human 119 
epithelial cells (Vica Pacheco et al., 1997). The prophage-encoded PblA and PblB platelet 120 
binding proteins of Streptococcus mitis strain SF100 play an important role in the 121 
pathogenesis, causing endocarditis (Bensing et al., 2001) and homologs with similar 122 
functions have been identified in prophage of Enterococcus faecalis (Matos et al., 2013).  123 
Bacterial type III secretion systems (TTSS) are associated with attachment and 124 
invasion by secreting effectors directly into target host cells. There are many examples of 125 
prophages that contribute to these systems in several intestinal pathogens. A cryptic 126 
prophage, CP-933C, has been reported to positively regulate a TTSS in E. coli (Flockhart et 127 
al., 2012). Deletion mutants of the cryptic phage displayed reduced colonisation and 128 
persistence in an ovine model, through a reduced ability to adhere to epithelial cells 129 
(Flockhart et al., 2012). The Salmonella typhimurium prophage-encoded SopE is an effector 130 
protein secreted via the TTSS into intestinal epithelial cells to promote invasion (Mirold et 131 
al., 1999). Likewise the CJIE1-like prophage, carried by some isolates of Campylobacter 132 
jejuni, confers increased adherence and invasion in vitro (Clark et al., 2012). This phage has 133 
also been shown to alter host protein expression in the presence of bile salts (Clark et al., 134 
2012). 135 
Contributions to fitness in vivo: Once bacteria have successfully colonised a host, 136 
they must reproduce and evade the host immune system.  Biofilms are a key feature of many 137 
bacterial infections and can be described as complex microbial communities, protected by a 138 
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secreted matrix of exopolysaccharides, proteins and DNA. Biofilm-associated bacteria 139 
exhibit increased resistance to immune attack and antibiotic treatment. Both active and 140 
cryptic prophage have been suggested to play a role in biofilm development of several 141 
pathogens, including S. pneumoniae (Carrolo et al., 2010), Bacillus anthracis (Schuch & 142 
Fischetti, 2009) and E. coli (Wang et al., 2010). Homologs of the filamentous phage Pf4, are 143 
widespread in clinical P. aeruginosa isolates, and play a crucial role in several stages of 144 
biofilm maturation. In particular Pf4 switches to a super-infective form within mature 145 
biofilms, aiding dispersal. This has been associated with increased virulence in a mouse 146 
model of infection (Rice et al., 2009).  147 
Enhanced growth rate upon lysogenic conversion is a common phenomenon (Bondy-148 
Denomy & Davidson, 2014). The prophage SMP increases both growth rate and resistance to 149 
lysozyme resulting in enhanced virulence of its Streptococcus suis host (SS2) in a zebrafish 150 
model of infection (Tang et al., 2013).  A reduced rate of growth has been observed when 151 
cryptic prophages are deleted from E. coli K12 compared to wild-type (Wang et al., 2010). 152 
Mutational studies of the Liverpool Epidemic Strain (LES) of P. aeruginosa (isolated from 153 
the lungs of patients with cystic fibrosis (CF)), revealed a significant association of prophage 154 
genes with competitiveness in a rat model of chronic lung infection (Winstanley et al., 2009). 155 
Mutations in several prophage genes exhibited up to 1000 fold reduced ability to establish 156 
infection and modified the expression of multiple virulence genes, including key factors 157 
associated with chronic infection (Lemieux et al., 2015). These studies suggest that temperate 158 
phage influence multiple stages of infection and alter the fitness of phage-carrying bacteria in 159 
the host environment.  160 
Immune modulation and antimicrobial resistance: Some prophage confer bacterial 161 
traits that are capable of actively modulating the immune system. Shiga toxin, produced by E. 162 
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coli Stx-phage, is capable of inhibiting the innate immune response of human enterocytes by 163 
inhibiting the PI3K/Akt/NF-B signalling pathway. This leads to a subsequent decrease in 164 
chemokines CCL20 and interleukin-8, which are linked with the innate immune response 165 
(Gobert et al., 2007). Several temperate phage of P. aeruginosa have been shown to convert 166 
non-mucoid strains to mucoidy, a phenotype characterised by the overproduction of the 167 
polysaccharide alginate (Miller & Renta Rubero, 1984). This phenotype provides bacteria 168 
with a physical protectant that helps them to be refractory to both the immune system (Cabral 169 
et al., 1987) and to antibiotic treatment (Hentzer et al., 2001). 170 
Antimicrobial resistance (AMR) genes have been identified on phage isolated from 171 
water (Colomer-Lluch et al., 2011), activated sludge (Parsley et al., 2010), faecal samples 172 
(Quirós et al., 2014), and the lungs of individuals with CF (Fancello et al., 2011). These 173 
genes can be transduced, changing the antimicrobial susceptibility profile of their host 174 
(Zhang & LeJeune, 2008, Mazaheri Nezhad Fard et al., 2011). An important example of this 175 
includes the transfer of the Staphylococcal cassette chromosome mec (SCCmec), a defining 176 
feature of Methicillin Resistance S. aureus (MRSA). This pathogenicity island can harbour 177 
several AMR determinants that are transferable by phage (Maslanova et al., 2013). Phage of 178 
bovine Salmonellae have been shown to transduce the blaCMY-2 gene, encoding resistance to 179 
third-generation cephalosporins (Zhang & LeJeune, 2008) and the Staphylococcal phage, 180 
TEM123 (isolated from food), was shown to confer beta-lactam resistance via a metallo-β-181 
lactamase gene (Lee and Park, 2015).  In this way, phage have been described as “vehicles of 182 
the resistome” and metagenomic analysis of DNA from the respiratory tract of CF patients 183 
has revealed the presence of phage-associated AMR genes (Rolain et al., 2011). Modi et al., 184 
(2013) observed an increase in phage-associated AMR genes in vivo following antibiotic 185 
treatment of mice. Interestingly, they detected enrichment of disparate mechanisms to resist 186 
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both the administered drug and un-related antibiotics. Furthermore, the evolved phage were 187 
shown to transfer AMR to naïve cultures from mouse microbiota. These findings suggest that 188 
phages play an important role in driving the evolution and spread of resistance and should be 189 
considered in control measures.  190 
 191 
Phage abundance in the human environment 192 
A phenomenal diversity of phage has been described in the natural environment, in 193 
the region of 50 viral species per litre of sea water, and up to 1 million species in 1 kg of 194 
marine sediment (Rohwer & Thurber, 2009). Prophages have been identified in ~ 60% of 195 
sequenced bacterial genomes (Roux et al 2015). The influence of bacteriophages on the life 196 
histories and evolution of their hosts in these environments is multi-faceted.  In addition to 197 
the selective pressures of predation, horizontal transfer of important genes (e.g. those 198 
involved in stress response, chemotaxis and metabolic pathways) aid niche adaptation 199 
(Rohwer & Thurber, 2009). There is less known about the density of natural bacteriophage 200 
populations in vivo, and particularly during bacterial infections. Phage virions have been 201 
detected in human sputa and faeces by electron microscopy (Ojeniyi et al., 1991) and isolated 202 
using plaque assays (Furuse et al., 1983, Fothergill et al., 2011). These studies report E. coli 203 
phage (coliphage) titres of up to 10
5
 p.f.u. g
-1
 human faeces (Dhillon et al., 1976) and an 204 
association has been identified between high coliphage densities (>1 x 10
5
 p.f.u. g
-1
) and 205 
disease (Furuse et al., 1983). Others have observed a shift from predominantly temperate, to 206 
virulent phages associated with human diarrhoeal disease; a reflection of modified intestinal 207 
microflora. 208 
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Metagenomic studies have begun to describe the human virome and have indicated 209 
that phage far out-weigh eukaryotic viruses both in number and diversity (Willner et al., 210 
2011, Reyes et al., 2012). Sequencing techniques are not dependent on plaque assays to 211 
detect phages and can thus enumerate total phage abundance without the need for a 212 
susceptible bacterial host. An estimated 10
8
–10
9 
bacteriophage particles per gram of human 213 
faeces (Kim et al., 2011), and approximately 10
3
 virotypes (mainly temperate) have been 214 
identified (Breitbart et al., 2003). 236 and 175 viral species have been identified in the oral 215 
cavity and the respiratory tract respectively (Willner et al., 2009, Willner et al., 2011). 216 
Temporal, spatial and inter-individual variation in virome diversity has been observed in the 217 
gastro-intestinal tract (Kim et al., 2011), oral cavity (Pride et al., 2012) and respiratory tract 218 
(Willner et al., 2009). However, there is little known about the balance between active phage 219 
virion densities and prophages in vivo. The development of new bio-informatic tools, such as 220 
VirSorter (Roux et al., 2015) that can assemble viral genomes from metagenomic and single-221 
cell amplified genome data, hold promise for the elucidation of this dynamic phage-host 222 
relationship in complex communities. 223 
Effects of antibiotic treatment: It is well established that some antibiotics can 224 
trigger the switch between lysogenic and lytic phage lifecycles; particularly the 225 
fluoroquinolones, that affect DNA replication. Production of Clostridium difficile phages, 226 
isolated from human faeces, has been shown to increase by 4-5 logs in response to 227 
fluoroquinolone treatment (Meessen-Pinard et al., 2012).  Ciprofloxacin has been 228 
demonstrated to trigger the V583 phage lytic cycle in E. faecalis This antibiotic is routinely 229 
used in therapeutic regimes including in the management of P. aeruginosa infection in (CF) 230 
(Fothergill et al., 2011, Matos et al., 2013).  This has been linked with both upregulation of 231 
phage-related genes (Cirz et al., 2006) and increased production of phage virions (Fothergill 232 
et al., 2011). Free P. aeruginosa phage have been detected at high levels in CF patient sputa, 233 
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most likely as a result of induction by antibiotics and oxidative stress (James et al., 2012, 234 
James et al., 2015). Norfloxacin is a well-known inducer of stx-phage from STEC, resulting 235 
in increased toxin production (Matsushiro et al., 1999). Clinicians are therefore advised to 236 
avoid treatment of suspected STEC infection with fluoroquinolones (Nassar et al., 2013).  237 
Long-term antibiotic treatment is likely to play a crucial role in the dynamics between 238 
prophage and their hosts in vivo.  A longitudinal study of CF patient sputa tracked the density 239 
of six P. aeruginosa phage that are all maintained as active prophages in the same LES 240 
chromosome. A consistently high density of DNA from LES phage virions (10
4
 – 241 
10
9 
copies µl−1) was observed
 
that correlated positively with LES host numbers over a 2 year 242 
period. Free-phage density exceeded specific bacterial host density (11-90-fold), consistent 243 
with ongoing lytic activity. This was expected as CF patients are often treated with high 244 
doses of intravenous antibiotics during exacerbation of symptoms. Surprisingly, there was no 245 
correlation between LES phage density and treatment of exacerbated symptoms. These 246 
patients were subject to variable cocktails of different antibiotic classes over several years 247 
irrespective of exacerbations (James et al., 2015). Not all antibiotics induce the phage lytic 248 
cycle; in fact some are known to supress lytic activity (Fothergill et al., 2011). As next 249 
generation sequencing technologies advance, the interaction between antibiotics, phage and 250 
their hosts during chronic infections can be teased apart in further longitudinal studies. 251 
 252 
Role of phage in bacterial adaptation 253 
It is no surprise that phage can be intimately involved in the adaptation and evolution 254 
of their bacterial hosts to drive bacterial diversification through numerous mechanisms. Lytic 255 
bacteriophages obligately kill their hosts placing a strong antagonistic selective pressure on 256 
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bacteria to avoid infection. The “kill the winner” hypothesis posits that the competition 257 
specialists in a bacterial population become targets of bacteriophages. The subsequent 258 
reduction in the “winners” selects for diversity in the population (Winter et al., 2010). The 259 
obvious effects of lysogenic conversion of bacterial hosts have been well documented. The 260 
carriage of additional genes during lysogeny can increase bacterial population diversity 261 
through a less antagonistic selection pressure than lytic infection. However, the more subtle 262 
effects of temperate phage on the adaptation of bacterial populations require further 263 
exploration. Temperate bacteriophages can also drive host genome evolution through gene 264 
disruption, duplication, transduction or by acting as anchor points for major chromosomal 265 
rearrangements. 266 
Gene Disruption frequently occurs through insertional inactivation. As an example 267 
of negative lysogenic conversion, Staphylococcal phage L54a has been shown to integrate 268 
into the lipase-encoding gene (geh) resulting in a loss of phenotype (Lee & Iandolo, 1986). 269 
Another S. aureus phage, φ13, has integrated into the 5' end of the hlb gene, causing a loss of 270 
beta-toxin expression (Coleman et al., 1991). E. coli phage Mu (mutator) was the first 271 
identified example of a bacteriophage causing mutations in the host chromosome. Mu 272 
lysogens were observed to display differences in their nutritional requirements through 273 
phage-mediated disruption of gene function (Taylor, 1963). Phage Mu is transposable, 274 
meaning it can integrate into random sites of the host chromosome (Bukhari & Zipser, 1972) 275 
unlike many other phage, including λ and φ13 which only integrate at specific sites. 276 
Transposable P. aeruginosa phage are commonplace, and include D3112 (Wang et al., 2004) 277 
B3 (Braid et al., 2004) and LES φ4 (Winstanley et al., 2009). D3112 has been shown to 278 
cause mutations in PAO1 through insertional inactivation (Rehmat & Shapiro, 1983). 279 
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However, the true extent of the impact of phage-mediated gene disruption on bacterial 280 
evolution remains poorly understood. 281 
Transduction: Horizontal transfer of genetic material between bacterial genomes by 282 
a bacteriophage can occur by two different mechanisms. Both virulent and temperate phage 283 
types are capable of generalised transduction, which occurs during the lytic cycle of 284 
infection. Prior to cell lysis, phage heads are packaged with newly replicated phage genomes, 285 
but bacterial DNA can be mistakenly incorporated in place of the phage nucleic acid. Upon 286 
infection of another cell, the DNA is released into the cell cytoplasm and can potentially 287 
recombine with the host chromosome. 90% of temperate phage of the S. Typhimurium 288 
complex have been shown to perform generalised transduction in host bacterial populations 289 
(Ebel-Tsipis et al., 1972, Schicklmaier & Schmieger, 1995). Generalised transduction of 290 
AMR genes has been observed during induction of a multi-drug resistant strain of S. 291 
Typhimurium using the veterinary antibiotic, carbadox (Bearson et al., 2014). The recently 292 
characterised P. aeruginosa phage φPA3, originally isolated from sewage, is capable of 293 
infecting clinical CF isolates. It has been shown to transduce mutations in quorum sensing 294 
genes (las and rhl) in cultures of the lab strain PAO1 (Monson et al., 2011).  295 
Specialised transduction is mediated only by temperate phage, and occurs during 296 
imprecise excision of prophage from the bacterial genome, taking with it adjacent bacterial 297 
gene(s), which are transferred to another bacterial host upon lysogenic infection. Specialised 298 
transducing λ phage have been shown to transduce several important genes (Kirschbaum & 299 
Konrad, 1973, Jaskunas et al., 1975, McEntee & Epstein, 1977, Hansen & von Meyenburg, 300 
1979). Other examples of specialised transduction have been identified in S. Typhimurium  301 
(Chan et al., 1972), Bacillus subtilis (Zahler et al., 1977) and P. aeruginosa (Cavenagh & 302 
Miller, 1986). 303 
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Anchors for Chromosomal Rearrangements: Prophage can act as anchor points for 304 
chromosomal inversions and other major genomic rearrangements. Sequencing of a 305 
pathogenic S. pyogenes isolate identified two major chromosomal inversions, one of which 306 
was caused by homologous recombination between two related prophages, and the other was 307 
suggested to occur after a phage integration event which caused an “unbalancing” of the 308 
genome (Nakagawa et al., 2003). There is evidence of a prophage-mediated chromosomal 309 
inversion in E. faecium, but despite the notion that major chromosomal rearrangements would 310 
have a negative impact on fitness, no such effect was detected (Lam et al., 2012). 311 
 312 
Polylysogeny 313 
Polylysogeny, the carriage of multiple prophages, is a common feature of bacterial 314 
pathogens. The genomes of a wide range of C. difficile strains are highly plastic; carrying 315 
multiple prophages (Hargreaves et al., 2015). Similarly, 18 co-existing prophages and 6 316 
prophage-like elements have been identified in the chromosome of E. coli O157:H7 strain 317 
RIMD0509952 (Hayashi et al., 2001). STEC are known to harbour several stx-encoding 318 
phage in the same chromosome, some of which exist in multiple copies, going against the 319 
classic lambdoid mechanisms of phage immunity. In this way, the expression of phage-320 
encoded genes can be enhanced. For example multiple isogenic infections of E. coli by stx-321 
phages have been shown to have a cumulative effect on the expression of Shiga toxin (Fogg 322 
et al., 2012). There are several reports of polylysogenic E. faecalis that have been isolated 323 
from clinical samples. Strain V583 harbours seven different prophage-like elements, six of 324 
which constitute fully active, inducible, prophages that encode clear virulence traits and 325 
interact with each-other (Matos et al., 2013). Similarly, the infection dynamics of multiple 326 
active LES prophages of P. aeruginosa have been described (Table 2). As with other 327 
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polylysogenic systems, the LES prophage sequences are mosaic in nature; LESφ3 is largely a 328 
hybrid of LESφ2 and LESφ5 (Figure 2). Of five active prophages, three exhibit productive 329 
infection of other P. aeruginosa strains. There is an interesting relationship between these 330 
prophages as LESφ2 confers immunity to infection by LESφ3 and LESφ4, which do not 331 
prevent infection by LESφ2. The LES prophages are also inducible with fluoroquinolone 332 
antibiotics and exhibit a hierarchical nature, with LESφ2 density being consistently higher 333 
than the other LES phage in vivo and in vitro (James et al., 2012).  334 
Experimental evolution experiments have begun to explore the cost/benefits of 335 
polylysogeny and the interactions between co-habiting prophages. Carriage of two LES 336 
prophages has been shown to confer a competitive advantage over single lysogens during 337 
mixed infection in wax moth larvae (Burns et al., 2015). Within host competition of 11 338 
different E. coli prophages has also suggested a hierarchical relationship during stressful 339 
conditions. In these experiments, double lysogens were exposed to the potent inducing agent, 340 
mitomycin C. In most cases, the prophage with the fastest response to induce the lytic cycle 341 
showed a competitive advantage (Refardt, 2011). These studies suggest that interactions 342 
between prophages and diversity in phage immunity mechanisms can also alter the course of 343 
bacterial adaptation. 344 
CRISPR Immunity to temperate phage 345 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are widespread 346 
in bacterial genomes and act as an active defence mechanism to protect against bacteriophage 347 
infection (Barrangou et al., 2007). This mechanism of protection against virulent phage has 348 
been well documented. However, the relationship between CRISPR and temperate phage is 349 
less clear. Several reports suggest that CRISPR systems are negatively correlated with 350 
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lysogeny and there is evidence that E. coli CRISPRs prevent both lysogenic infection and 351 
induction of prophages (Fogg et al., 2010). Others have demonstrated an interaction between 352 
CRISPR and the prophage DMS3. The presence of both together has been shown to inhibit 353 
biofilm formation and swarming in P. aeruginosa (Zegans et al., 2009). CRISPR spacers 354 
with 100% identity to temperate phage sequences are widespread amongst clinical isolates of 355 
P. aeruginosa, including the LES (Cady et al., 2011). The overall effects of CRISPR 356 
evolution, in response to temperate bacteriophages, on bacterial adaptation require further 357 
exploration.  358 
 359 
Outlook 360 
The contribution of prophage to the success of their bacterial hosts during infection 361 
has been under studied, especially in the case of prophage that do not contribute a clear 362 
phenotype such as toxin production. A wealth of readily available whole-genome sequence 363 
data has now enabled the identification of previously un-discovered prophages and cryptic 364 
prophage elements, revealing their abundance in an array of different environments. 365 
However, biological understanding of the roles of the many “unknown” proteins harboured 366 
by the prophages remains some way behind the generation of these sequence data. In addition 367 
to this, there is a lack of functional studies into the mechanistic contributions of these phage 368 
to the host. Since temperate phage can switch between lysis and lysogeny, they are 369 
particularly important in the evolutionary dynamics of bacterial populations, leading to a 370 
complex interplay between symbiotic and competitive relationships of multiple interacting 371 
phage and their hosts. The additional influence of lysis-inducing antibiotic treatments can 372 
potentially change the trajectory of bacterial adaptation in the host environment. An 373 
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understanding of these infection dynamics in vivo is needed to develop novel strategies for 374 
managing chronic bacterial infection. 375 
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Figure 1. The temperate phage lifecycle.  
A: Lysogeny occurs when the phage DNA integrates into the bacterial genome. Here it is 
described as a prophage. Prophages replicate along with the bacterial cell. Cell stress such as 
DNA damage can result in the prophage entering the lytic cycle leading to phage replication 
and release following bacterial cell lysis. B: Scanning electron microscope image of an E coli 
cell under-going lysis triggered by the stx-phage Ф24B (James C. E. un-published). 
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Table 1: Prophage associated-genes involved in bacterial virulence. 
Bacteria Phage  Phage-encoded virulence gene(s) Reference 
C. 
diptheriae 
Beta  Diptheria toxin (tox) Cytotoxin  (Holmes and Barksdale 
1969) 
E. coli Stx 
 
Shiga toxin (stx1, stx2), cytotoxins 
stk - Affects signal transduction  
TTSS Effectors cif, espI/nleA, espI, 
espK, espEU/tccP, nleI 
(Wagner et al. 2001)  
(Plunkett et al. 1999)  
(Lavigne and Blanc-Potard 
2008) 
λ 
 
lom - binding to epithelial cells  
bor - Outer membrane protein that 
aids bacterial immune evasion.  
(Vica Pacheco et al. 1997)  
(Barondess and Beckwith 
1995) 
CP-933C  Cryptic phag  regulates TTSS (Flockhart et al. 2012)  
S. enterica φSopE TTSS effector (sopE) promotes 
invasion of epithelial cells. 
(Mirold et al. 1999)  
Gifsy-1  gipA, gogB - survival and growth in 
Peyer’s patches. 
(Stanley et al. 2000) 
Gifsy-2  sodC1, SseI - survival in 
macrophages 
(Figueroa-Bossi et al. 2001) 
Gifsy-3 sspHI - TTSS effector  (Ehrbar and Hardt 2005)  
P. 
aeruginosa 
D3  Altered outer membrane properties 
reduces phagocytosis 
(Holloway and Cooper 1962)  
S. mitis SM1 pblA and pblB - Platelet binding  (Bensing et al. 2001) 
C. jejuni CJIE1  Increased adherence and  invasion  (Clark et al. 2012) 
V. cholerae CTX  ctx - Cytotoxin (Faruque et al. 1998) 
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Table 2. Characteristics of LES prophage 
LES 
prophage 
Characteristics N
o
 of 
genes 
Related 
phages in 
reference 
strain PAO1 
Known 
related 
phages 
Interaction 
with other 
LES phages 
φ1 Defective prophage, 
predicted to encode 
pyocin R2 
19 Defective 
prophage 
gene cluster 
encoding 
pyocin R2 
Pyocin gene 
clusters 
predicted to 
have evolved 
from phage 
tail genes 
Unknown 
φ2 Active inducible 
prophage, encodes 
integrase for site-specific 
integration 
44 None None Confers 
resistance to 
infection by 
φ3 and φ4 
φ3 Active inducible 
prophage, encodes 
integrase for site-specific 
integration 
53 None Homologous 
regions in 
LESφ2 and 
LESφ5 
Shares same 
cI gene 
region as φ2 
φ4 Active inducible 
prophage, encodes 
transposase. Capable of 
random integration. 
48 None D3112 Present in 
100% LES 
isolates 
φ5 Active inducible 
prophage, encodes 
integrase 
65 None D3 Present in 
only a small 
proportion of 
LES isolates 
φ6 Active inducible 
prophage, encodes 
integrase 
12 Pf4 
filamentous 
phage 
implicated in 
biofilm 
dispersal 
Filamentous 
phage Pf1 
(Family 
Inoviridae) 
Unknown 
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Figure 2. Mosaicism of LES prophages. 
 
 
 
Circos map (Krzywinski et al. 2009) depicting an alignment of five prophage sequences from 
the Liverpool Epidemic Strain of Pseudomonas aeruginosa (EMBL accession number 
FM209186) using the Artemis Comparison Tool (Carver et al. 2005). Each coloured segment 
of the circumference represents a LES prophage genome. Ribbons that link prophage regions 
show regions of sequence homology. 
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